Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | 12 Parkinson's trials, 1 stopped | 0.93 |
| literature PubMed | 85 Parkinson's papers of 22,555 | 0.41 |
| pathways Reactome | 3 pathways; mostly lysosome and autophagy | 1.00 |
No case: the score is under the bar. Receipt 17006
Sealed predictions
- STS in dopamine neurons, braak+0.38 (p 0.316) → -0.11 (p 0.787)receipt 17013
Swarm cases
receipt 17013: STS in dopamine neurons, braak
- power
- full sample +0.12 (p 0.633, n 18), 95% CI -0.37 to +0.56. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.00 (p 0.997, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.14 (p 0.591, n 18). could be the mix.
- skeptic
- leave-one-out range -0.01 to +0.23, sign flips 2; without severely affected donors +0.12 (p 0.633, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for STS in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts